Suleika Jaouad Shares the Story of Her Leukemia Journey

October 4th 2025, 6:00pm

By Alex Biese

The author and advocate, facing leukemia for the third time in 15 years, sat down for an interview with CURE.

Top Genitourinary Cancer Stories From September to Know

October 4th 2025, 2:00pm

By Ryan Scott

As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, kidney and other cancers.

Understanding Stage 2 Kidney Cancer (Renal Cell Carcinoma)

October 3rd 2025, 9:00pm

By Ryan Scott

This guide on stage 2 kidney cancer covers key info, treatments and what to expect, helping you prepare for informed discussions with your care team.

Why Is Patient Advocacy Important During Breast Cancer Awareness Month?

October 3rd 2025, 8:00pm

By Jennie Smythe

Jennie Smythe, diagnosed with breast cancer at 41, now works with Susan G. Komen to amplify patient voices and drive progress in research and policy.

Reclaiming Intimacy for Women After Cancer

October 3rd 2025, 7:00pm

By Kelly Dyckman

Kelly Dyckman works to help women reclaim their confidence in intimacy following a cancer journey, as she explained in an interview with CURE.

A Cancer Portrait Hidden in the Attic of My Mind

October 3rd 2025, 5:31pm

By Felicia Mitchell

A breast cancer survivor reflects whimsically on how she might have aged with two breasts instead of one.

Active Surveillance or Treatment? Your Guide to Stage 1 Prostate Cancer Options

October 3rd 2025, 4:00pm

By Gina Mauro

This stage 1 prostate cancer guide explains diagnosis, Gleason scores, and the choice between surgery, radiation and active surveillance.

FDA Grants Orphan Drug Designation to AMXT 1501 With DFMO in Neuroblastoma

October 3rd 2025, 3:00pm

By Alex Biese

Neuroblastoma is the most common cancer in infants and most commonly occurs in children younger than 5 years old.

Sexual Health After Cancer: A Guide to Restoring Intimacy and Connection

October 3rd 2025, 1:00pm

By Gina Mauro

Kelly Dyckman discusses the mind-body connection during cancer care, offering tools for coping with diagnosis and intimacy struggles.

Remote Monitoring May Improve Recovery After Cancer Surgery

October 2nd 2025, 9:00pm

By Tracy Crane

FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer

October 2nd 2025, 8:05pm

By Alex Biese

The FDA has approved Zepzelca with Tecentriq or Tecentriq Hybreza for extensive-stage small cell lung cancer.

Lung Cancer Basics for Newly Diagnosed Patients

October 2nd 2025, 8:00pm

By Spencer Feldman

Lung cancer can be overwhelming, but learning about types, stages, treatments and support can help patients feel more prepared for their care journey.

How Lung Cancer Helped to Save My Life

October 2nd 2025, 5:00pm

By Sue McCarthy

Prior to my diagnosis with Stage 3B Lung Cancer, I had spent many years reading self-help books. I worked hard, but never felt successful, or took pride in myself.

September Blood Cancer Updates: What Patients Should Know

October 2nd 2025, 4:00pm

By Ryan Scott

Recent clinical trial results, real-world safety data, and patient experiences highlight meaningful advances in blood cancer care.

FDA Approves Guardant360 Test With Inluriyo for ESR1 Breast Cancer

October 2nd 2025, 3:00pm

By Spencer Feldman

The FDA approved Guardant360 CDx to identify adults with ESR1-mutated, ER-positive, HER2-negative breast cancer eligible for treatment with Inluriyo.